Clinical Trial Update: Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia [Phase 4]

View source ↗

Summary

Phase 4 trial investigating avatrombopag for thrombocytopenia in patients with liver failure and related conditions, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Liver Failure
• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Tongji Hospital | Conditions: Liver Failure, Thrombocytopenia | Phase 4 | Status: UNKNOWN